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Abstract
Background: Ethidium homodimer is a cell-membrane impermeant nuclear fluorochrome that
has been widely used to identify necrotic cells in culture. Here, we describe a novel technique for
evaluating necrosis of epithelial cells in the proximal tubule that involves perfusing ethidium
homodimer through the intact rat kidney. As a positive control for inducing necrosis, rats were
treated with 3.5, 1.75, 0.87 and 0.43 mg/kg mercuric chloride (Hg2+, intraperitoneal), treatments
which have previously been shown to rapidly cause dose-dependent necrosis of the proximal
tubule. Twenty-four h after the administration of Hg2+, ethidium homodimer (5 μM) was perfused
through the intact left kidney while the animal was anesthetized. The kidney was then removed,
placed in embedding medium, frozen and cryosectioned at a thickness of 5 μm. Sections were
permeabilized with -20°C methanol and then stained with 4',6-diamidino-2-phenylindole (DAPI) to
label total nuclei. Total cell number was determined from the DAPI staining in random microscopic
fields and the number of necrotic cells in the same field was determined by ethidium homodimer
labeling.
Results: The Hg2+-treated animals showed a dose-dependent increase in the number of ethidium
labeled cells in the proximal tubule, but not in other segments of the nephron. Other results
showed that a nephrotoxic dose of gentamicin also caused a significant increase in the number of
ethidium labeled cells in the proximal tubule.
Conclusion: These results indicate that this simple and sensitive perfusion technique can be used
to evaluate cellular necrosis in the proximal tubule with the three-dimensional cyto-architecture
intact.
Background
As a highly perfused organ having unique filtration, secre-
tory and reabsorptive functions, the kidney is susceptible
to toxic injury. Of the various segments of the nephron,
the proximal tubule is especially prone to toxic injury. As
a result of its location adjacent to the glomerulus and the
presence of specific secretory systems for organic acids and
bases, the proximal tubule is frequently exposed to higher
levels of toxicants than other segments of the nephron
and is, therefore, often a primary site of nephrotoxic
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injury. In light of its importance as a site of toxic injury,
considerable attention has been focused on the develop-
ment of sensitive and accurate methods for quantifying
cell injury and cell death in the proximal tubule. Obvi-
ously, a key issue in attempting to quantify toxic injury in
the proximal tubule is to identify dead or dying cells. The
techniques that have been used to accomplish this fall
into three categories: those based on changes in general
cell morphology; those based on biochemical markers in
the cascade of events leading to oncotic/necrotic or apop-
totic cell death; and those based on a loss of cell mem-
brane integrity [1-4].
Morphological analysis of whole kidney tissue is a simple
and widely used method to determine the nephrotoxic
effects of xenobiotics while keeping the three dimensional
cyto-architecture of the kidney intact [5,6]. However this
technique is semi-quantitative at best, with a necrotic/
apoptotic score or index assigned to a certain degree of cell
death or tissue damage. Ultimately this method is largely
based on an observer's judgment as to whether a cell is
dead or alive.
Several methods of identifying cell death in the kidney are
based on specific markers of key biochemical events in the
process of necrosis/oncosis or apoptosis, for reviews see
[2,3,7]. For example, DNA fragmentation is one defining
characteristic of apoptotic cell death and assays based on
the Terminal Deoxynucleotidyltransferase-Mediated UTP
End Labeling (TUNEL) and electrophoretic analysis of
DNA have been primarily used to detect apoptotic cell
death [8-10], although the TUNEL assay does not always
discriminate apoptotic from necrotic or autolytic cell
death [11]. Other assays have utilized specific markers of
key events in the process of apoptosis or necrotic cell
death. Some of the markers on which these assays are
based include the mitochondrial membrane permeabili-
zation, the translocation of phosphatidyl serine from the
inner to the outer cell surface, and the activation of cas-
pase or calpain enzymes [12-14]. These assays have the
advantage of indicating the exact stage of progression of
cell death. However, these assays can not always be used
in the intact kidney and they can be difficult to interpret.
Furthermore, the assays may be subject to interferences by
the toxic substances themselves [15,16].
Some of the most widely used methods for assessing via-
bility are based on the loss of cell membrane integrity that
occurs prior to cell death [17]. Many of these methods
based on cell membrane permeability involve the detec-
tion of cytosolic enzymes such as lactate dehydrogenase
(LDH) and alkaline phosphatase that appear in the urine
as the apical membrane of the epithelial cells of the prox-
imal tubule begin to break down. These enzymatic assays
are rapid, quantitative, and relatively easy to perform.
However, many of the enzymatic urinary markers of cell
death are not cell- or even organ-specific. For example,
with toxic agents such as cadmium, that cause hepatic as
well as renal damage, urinary enzymatic markers of cell
death are not an ideal method to determine renal damage.
Furthermore, certain substances can inhibit or interfere
with the actual enzyme activity. For example, the nephro-
toxic metal Hg2+  directly inhibits LDH activity [18].
Recently, several commercially–available ELISA-based
assays have been developed for the determination of uri-
nary alpha-glutathione-S-transferase, a urinary marker
that is thought to be specific for proximal tubule damage
[19]. However these products are rather expensive and
have yet to be fully validated for use in assessing the effects
of most nephrotoxic substances.
Other techniques to assess cell necrosis through the loss of
cell membrane integrity involve the use of cell membrane-
impermeable dyes such as trypan blue, or fluorochromes
such as various ethidium or propidium compounds
[15,20]. These agents are normally excluded from live
cells but can label dead or dying cells in which cell mem-
brane integrity is compromised. While these methods
have been widely used for assessing necrotic cell death in
in vitro model systems they have been less widely used for
in vivo studies.
While considering the assessment of renal viability in an
intact kidney it is important to acknowledge work done by
Molitoris and colleagues and Peti-Peterdi and co-workers,
who have pioneered the use of multiple photon fluores-
cence microscopy to study renal physiological and bio-
chemical processes in vivo [20-22]. This powerful
technique involves the use of nuclear fluorochromes and
allows for the real time quantification of apoptotic and
necrotic renal cell death in the intact kidney in a live ani-
mal [23]. However this technique requires considerable
technical expertise along with the use of very expensive
equipment. Moreover, the optical constraints limit its use
to the visualization of functional changes only in the out-
ermost areas of the exposed regions of the kidney.
As part of our ongoing research to identify the mechanism
underlying the nephrotoxic effects of cadmium (Cd2+)
and other metals, we have developed a novel in situ renal
cell viability assay that involves perfusing the fluorescent
cell viability marker, ethidium homodimer through the
intact rat kidney. Ethidium homodimer is a nuclear fluor-
ochrome with high affinity for DNA (Ka = 2 × 108 M-1), a
molecular weight of 856.8 and low membrane permeabil-
ity [24]. Traditionally, ethidium homodimer has been
widely used as an indicator of necrosis of cells in culture.
However it has also been used as a marker of necrosis in
specific populations of cells within isolated corneae [25]
and in whole lung preparations [26-28].BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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To validate the sensitivity and utility of this assay, rats
were treated with known nephrotoxic doses of Hg2+.
Hg2+primarily accumulates within and targets the epithe-
lial cells of the proximal tubule, especially at the junction
of the cortex and medulla [29-31]. Exposure to nephro-
toxic concentrations of Hg2+ results in renal dysfunction
as indicated by elevations in blood urea nitrogen (BUN)
and serum creatinine [32]. At the cellular level, Hg2+ expo-
sure is associated with oxidative stress, decreased reduced
glutathione levels [33], alterations in stress protein expres-
sion [29,34] and alterations in cell adhesion molecule
expression and localization [32]. Acute exposure to neph-
rotoxic doses of Hg2+ results primarily in necrosis with
apoptotic cell death occurring to a lesser extent at very
high doses of Hg2+ [35]. In order to further evaluate the
utility of this technique for assessing pathological changes
in the proximal tubule, additional animals were treated
with the aminoglycoside antibiotic gentamicin at a dose
(100 mg/kg for 8 consecutive days) that has previously
been shown to cause necrosis of the proximal tubule [36].
In addition, other animals were treated with the nephro-
toxic metal Cd2+, using a subchronic dosing protocol (0.6
mg/kg 5 days per week for 6 weeks) that causes dysfunc-
tion of the proximal tubule without causing extensive
tubular necrosis [37-39].
The results of these studies show that perfusion of the
whole kidney with ethidium homodimer allows for the
accurate determination of cell death in conditions where
the three-dimensional cyto-architecture of the kidney
remains intact.
Results
No animals died in any of the treatment groups. However,
animals in the 3.5 mg/kg Hg2+ treatment group appeared
lethargic with orange-colored bristly fur, especially
around the neck at 24 h following Hg2+ exposure. Others
have noted similar responses in rats using similar doses of
Hg2+ [29]. In general, the abdominal cavity of animals
dosed with 3.5 mg/kg HgCl2 tended to have visceral con-
nective tissue that appeared to be dehydrated or "sticky".
Subsequently the clearing of connective tissue from the
aorta and kidneys for the in situ viability assay was more
difficult and required slightly more time in the higher
Hg2+-treatment groups, as compared to control animals.
Macroscopic observations of the unperfused, right kidney
demonstrated a pale coloration of the cortex and medulla
in animals treated with 3.5 mg/kg Hg2+.
Effects of Hg2+ on serum and urinary parameters
Hg2+ treatment had a biphasic, dose-dependent effect on
urine volume (Fig. 1A). Moderate doses of Hg2+ (0.875
mg/kg) caused an increase in urine volume. However, the
highest doses of Hg2+ (3.5 mg/kg) resulted in a trend of
decreasing mean urine volume values that was not statis-
tically significant. The urinary excretion of protein also
showed a trend toward this type of dose-dependent,
biphasic response, although differences in mean values
did not reach levels of statistical significance (Fig. 1B).
Treatment with the highest dose of Hg2+ caused a signifi-
cant decrease in the urinary excretion of creatinine (Fig.
1C). This high dose of Hg2+ also caused a significant
increase in serum creatinine and BUN (Figures 2A and
2B). The results in Figures 1(A–C) and 2(A, B) are similar
to results that have been reported by other investigators
using similar Hg2+-treatment protocols in rats [32,40] and
indicate that after 24 h the highest doses of Hg2+ caused
severe acute renal failure and the lower doses caused less
severe impairment of renal function.
Figure 3 shows H & E stained sections of representative
samples of the outer renal cortex from control and Hg2+-
treated animals. Figures 3(A–C) shows images of the non-
perfused right kidney taken with a 40× objective. The epi-
thelial cells of the proximal tubules of control animals
(3A) exhibited regular cuboidal shapes, well-defined
nuclei and were closely associated with adjacent cells.
Panels D-F of Figure 3 show images of comparable fields
from the perfused left kidneys from the same animals
from which the panels A-C (non-perfused right kidney),
were obtained. As expected, the perfused, left kidneys all
contained fewer blood cells than the corresponding non-
perfused right kidneys. However, in all other respects, the
perfused kidney showed the same morphologic properties
as the corresponding non-perfused kidneys; the samples
from the Hg2+-treated animals showed evidence of dose-
dependent necrosis in the proximal tubule. Furthermore,
perfused (3D) and non-perfused (3A) kidneys of control
animals showed no signs of cell death or damage. This
indicates that the perfusion technique did not cause any
morphologic changes in the proximal tubules. Images
taken with a 10× objective (Fig. 3H) show that at a dose of
0.875 mg/kg Hg2+ the boundary between the cortex and
outer medulla is more distinct compared to the 3.5 mg/kg
Hg2+ dose (Fig. 3I). In the images taken with a 40× objec-
tive, samples from the 0.875 mg/kg Hg2+-treated animals
(Fig. 3B, 3E) some swelling of epithelial cells in the prox-
imal tubule was apparent coupled with a modest loss of
nuclei. However, epithelial cells appeared to remain
attached to the basement membrane. In samples from the
3.5 mg/kg Hg2+-treated animals (Fig. 3C, 3F) the epithe-
lial cells throughout the proximal tubule were swollen
and appeared to slough off from the basement mem-
brane. Furthermore, the 3.5 mg/kg Hg2+-treated animals
demonstrated a loss of nuclei with widespread degenera-
tion and necrosis. In general, the glomeruli and distal
tubules from the Hg2+-treated animals showed normal
morphology. These effects of Hg2+ are similar to those
reported in other studies [32,34,41] and indicate thatBMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
Page 4 of 14
(page number not for citation purposes)
Effects of Hg2+ on urine volume (A), urinary protein (B) and urinary creatinine (C) Figure 1
Effects of Hg2+ on urine volume (A), urinary protein (B) and urinary creatinine (C). Animals received single, ip injections of var-
ying Hg2+ doses (0.437, 0.875, 1.75 and 3.5 mg/kg) and 24 h urine volume samples were collected and analyzed for creatinine 
and protein as described under methods. The values for each data point represent the mean ± SE for a total n ≥ 6 for each 
treatment group. An asterisk (*) indicates significant difference from control (one-way ANOVA, P < 0.05, post-hoc Tukey's 
test).BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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Effects of Hg2+ on serum creatinine (A) and BUN (B) Figure 2
Effects of Hg2+ on serum creatinine (A) and BUN (B). Animals received single, ip injections of varying Hg2+ doses (0.9% NaCl 
vehicle control, 0.437, 0.875, 1.75 and 3.5 mg/kg) and 24 h blood samples were collected and analyzed for BUN and serum cre-
atinine. The values for each data point represent the mean ± SE for a total n ≥ 6 for each treatment group. An asterisk (*) indi-
cates significant difference from control (one-way ANOVA, P < 0.05, post-hoc Tukey's test).BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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Hg2+ caused extensive necrosis of the proximal tubule but
had little effects on other segments of the nephron.
Effects of Hg2+ on ethidium-labeling in the renal cortex
Cryosections of the ethidium-perfused kidneys from con-
trol and Hg2+-treated animals were fixed, permeabilized
and stained with DAPI, as described in the Methods sec-
tion. Figure 4 shows representative images that were cap-
tured from random fields of the renal cortex of control
and Hg2+-treated animals. Figure 4A–C show the sample
fields under phase contrast imaging. Figure 4D–F show
the DAPI labeling and Figure 4G–I show the ethidium
labeling. As expected, there was almost a complete
absence of ethidium labeling in the nuclei of the samples
from control animals (Fig. 4G). However, animals treated
with 3.5 mg/kg Hg2+ show a significant increase in the
number of ethidium-labeled cells in the proximal tubule
(Fig. 4H). Low powered (10× objective) images of 3.5 mg/
kg Hg2+-treated animals (Fig. 4I) show that the ethidium-
labeling was confined to the renal cortex, and outer
medulla, but was absent in the inner medulla (arrow)
these results are in agreement with previous studies show-
ing that the proximal tubules are the primary site of Hg2+
toxicity [30,31,35].
Dose-response relationship for the effects of Hg2+ on 
proximal tubule epithelial cell viability
To test the sensitivity of the in situ viability assay, animals
were treated with varying doses of Hg2+ (0.4375, 0.875,
1.75 and 3.5 mg/kg). The results are summarized in Figure
5. Figure 5A–C shows the sample fields under phase con-
trast imaging. Figure 5D–F shows the DAPI labeling and
Figure 5G–I shows the ethidium labeling. There was
almost a complete absence of ethidium labeling in the
nuclei of the samples from control animals (Fig. 5G).
However, at Hg2+ doses of 0.875 (Fig. 5H) and 1.75 mg/
kg (Fig. 5I) there was an increase in the number of ethid-
ium-labeled nuclei of proximal tubule epithelial cells in
the renal cortex compared to images from control animals
(Fig. 5G). The dose-response relationship of Hg2+-
induced renal cell death is shown graphically in Figure 6.
Note that the lowest dose of 0.4375 mg/kg Hg2+ did not
cause a significant increase in the number of ethidium-
labeled cells but the higher doses, 0.875, 1.75 and 3.5 mg/
kg showed significant dose-dependent increases in the
percent of ethidium-labeled cells. This dose-response of
Hg2+-induced renal necrosis is consistent with the mor-
phological observations described in Fig. 3 and is similar
to those reported in other studies using non-quantitative
or semi-quantitative morphological analyses
[31,33,35,42].
Effects of gentamicin and Cd2+ on renal cell viability
In order to further evaluate the utility of this technique for
assessing pathological changes in the proximal tubule,
additional animals were treated with the aminoglycoside
antibiotic gentamicin (n = 2) at a dose that has previously
been shown to cause necrosis of the proximal tubule [36].
Animals treated with gentamicin for 24 h excreted larger
volumes of urine (mean values of 34.1 and 140.9 ml/kg/
24 h for control and gentamicin-treated, respectively) and
displayed elevations in urinary protein content (mean val-
ues of 34.8 and 172.9 mg/kg/24 h for control and gen-
tamicin-treated, respectively). These findings are similar
to those reported in the literature [43] and are characteris-
tic of gentamicin nephrotoxicity. In addition, other ani-
mals were treated with the nephrotoxic metal Cd2+, using
a sub-chronic dosing protocol (0.6 mg/kg, sc, 5 days per
week for 6 weeks) that has previously been shown to
cause dysfunction of the proximal tubule without causing
tubular necrosis [37-39]. Urine samples from 6 week
Cd2+-treated animals showed significant proteinuria (38.6
± 4.1 and 50.5 ± 3.8 mg/kg/24 h for control and Cd2+-
treated (n = 12), respectively) and decreased body weight
gain. However, there were no changes in urine volume or
creatinine excretion (data not shown). Figure 7 shows the
results of the renal cell necrosis assay in samples from ani-
mals that had been treated with either gentamicin (Fig. 7J)
or Cd2+  (Fig. 7L). Animals treated with the proximal
tubule-specific nephrotoxic, gentamicin, demonstrated a
significant increase in the percent of ethidium
homodimer labeled cells (Fig. 7J). In the samples from the
gentamicin-treated animals 21 ± 9% of cells were labeled
with ethidium as opposed to < 1.0% in the control sam-
ples (n = 3 fields from 2 control and 2 gentamicin-treated
animals). None of the samples from the Cd2+-treated ani-
mals exhibited signs of necrosis in the renal cortex (Fig.
7L). This is in agreement with previous studies using the
identical treatment protocol [38].
Discussion
In examining the nephrotoxic effects of xenobiotics, one
of the most important endpoints that investigators must
evaluate is cell death. Unfortunately, the tasks of identify-
ing and quantifying dead or dying cells in a complex
organ such as the kidney are not as easy as they may
appear to be at first glance. In the current report, we
describe a relatively simple procedure for identifying and
quantifying necrotic cells in the proximal tubule that
involves the perfusion of the intact kidney with ethidium
homodimer and the subsequent observation of fluores-
cence of cryosections from the renal cortex. Furthermore,
we show that this technique can be used to detect changes
in cell viability resulting from other site-specific nephro-
toxicants such as gentamicin. This would indicate the pos-
sible utility of employing this in situ viability assay for a
wide variety of potential nephrotoxicants.
This method offers a couple of significant advantages over
many of the other techniques that have been used toBMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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assess the cell viability/cell death in the intact kidney.
First, while the method does require some surgical prepa-
ration of the animal, it is relatively easy to perform and it
does not require the use of elaborate or expensive equip-
ment. Secondly, the labeling of cell nuclei with ethidium
homodimer provides a very clear-cut end point for identi-
fying necrotic cells. A random analysis of the pixel density
indicated that the intensity of light emission of almost all
of the ethidium homodimer labeled cells was at least 10–
100 times the intensity of background labeling (data not
shown). There were few, if any, cells that exhibited inter-
mediate levels of labeling. This makes it easy for the
observer to interpret the results; the nuclei are either
labeled or they aren't and the delineation is very clear cut.
Also, since the delineation between live and necrotic cells
is so clear cut, it should be possible to interface this tech-
nique for use with quantitative image analysis and statis-
tical programs.
The renal perfusion technique that was used in these stud-
ies is similar to renal perfusion procedures that have been
used by others to harvest renal epithelial cells for cell cul-
ture or to infuse markers for the evaluation of renal func-
tion [44-46]. In the procedure described in this study, the
The effects of Hg2+ on the general morphology of the outer renal cortex Figure 3
The effects of Hg2+ on the general morphology of the outer renal cortex. Rats were treated with Hg2+ (0.9% NaCl vehicle con-
trol, 0.875 and 3.5 mg/kg, i.p.). 24 h later, the kidneys were removed, and processed for H & E staining. Panels A-C are repre-
sentative sections from the non-perfused right kidney and panels D-F are representative sections from the perfused left kidney 
under high-power (HP). (G-I) are representative images of the perfused left kidney under low-power (LP). Panels A, D, G are 
from vehicle control treated animals, panels B, E, H are from 0.875 mg/kg Hg2+-treated animals and panels C, F, I are from 3.5 
mg/kg Hg2+-treated animals. A white arrow in panels H and I represent the boundary between the renal cortex and the outer 
medulla. The scale bar in the top left image represents 100 μm and the scale bar in the bottom left image represents 500 μm.BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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ureter is sectioned and the perfusion pressure (50–100
mmHg) is below that of reported rat systolic blood pres-
sure [47]. This low pressure tubular perfusion procedure
has little effect on general renal morphology (see Fig. 3).
Since the perfusion procedure washes most of the blood
cells from the kidney, the morphology and cyto-architec-
ture of the proximal tubules in the perfused kidneys is
actually clearer and better preserved than in non-perfused
kidneys. Since the morphology of the kidney is so well-
preserved, it should be possible to adapt this procedure to
include fixatives and labels or markers of specific mole-
cules and physiologic functions of interest.
One caveat to keep in mind regarding this method is that
it is based on the loss of cell membrane integrity, which is
a relatively late event in the process of cell death [48]. It
does not assess the early stages of cellular injury. This is a
significant issue because an increasing volume of evidence
indicates that some nephrotoxic substances can have pro-
found effects on renal function, without causing necrosis.
One example of such a substance is Cd2+. The results of
our studies utilizing this new technique confirm results of
previous studies from this and other laboratories [37-39]
indicating that subchronic exposure to Cd2+ for 6 weeks
causes proximal tubule dysfunction without causing sig-
Effects of Hg2+ on ethidium-labeling in the renal cortex Figure 4
Effects of Hg2+ on ethidium-labeling in the renal cortex. Animals were treated with Hg2+ (3.5 mg/kg, ip) for 24 h and the left kid-
neys were infused with ethidium homodimer. Cryosections of the kidneys were then fixed, permeabilized and labeled with 
DAPI as described in the Methods section. Panels A, D, G are high-powered (HP) images from control animals and panels B, E, 
H are from 3.5 mg/kg Hg2+-treated animals. Panels C, F, I represent low-powered (LP) images from 3.5 mg/kg Hg2+-treated ani-
mals. Panels A-C show phase-contrast images of the same fields in D-F and G-I, respectively. Panels D-F show total nuclei 
labeled in each field by DAPI, G-I show labeled nuclei by ethidium homodimer. The white arrow in panel I indicates the bound-
ary between inner medulla and the renal cortex. The scale bar in the top left image represents 100 μm and the scale bar in the 
top right image represents 500 μm.BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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nificant necrosis of tubular epithelial cells. It should be
noted that some studies have shown that this Cd2+ treat-
ment protocol causes a limited level of apoptosis in the
proximal tubule [37,39]. While we did not specifically
address the issue of Cd2+-induced apoptosis in the present
study, we feel that this method could eventually be
adapted for this purpose. In this procedure, ethidium
homodimer, which is infused through the intact kidney,
labels necrotic cells preferentially. However the DAPI
staining occurs after the cells are permeabilized with
methanol and labels all necrotic, apoptotic and unaf-
fected cell nuclei. Apoptotic nuclei appear to have a dis-
tinctive fragmented or diffuse appearance that
distinguishes them from necrotic or normal cells
[5,49,50]. Therefore through close examination of nuclei
labeled with DAPI [51], it may be possible to determine
the ratio of necrotic to apoptotic cells using this method.
It should also be noted that while the present studies
focused on the use of ethidium homodimer to evaluate
cell death in the proximal tubule, the technique has the
potential to identify cellular necrosis in other segments of
the nephron.
Another notable limitation of this technique is that it
essentially provides a "snapshot" image of cellular necro-
sis in the kidney at a single point in time. Obtaining data
for multiple time points requires the use of multiple ani-
mals. This is in contrast to the more sophisticated multi-
ple photon imaging techniques that allow for real time
imaging of the kidney of a single animal over time [20-
22]. Despite this shortcoming, the ethidium homodimer
labeling technique is relatively easy to perform, inexpen-
sive and should provide a useful means for quantifying
Dose-response for Hg2+-induced cell death Figure 5
Dose-response for Hg2+-induced cell death. Animals were treated with Hg2+ (0.875 and 1.75 mg/kg, ip) for 24 h and the left 
kidneys were infused with ethidium homodimer. Cryosections of the kidneys were then fixed, permeabilized and labeled with 
DAPI as described in the Methods section. Panels A, D, G are images from 0.9% NaCl vehicle control-treated animals. Panels 
B, E, H are from 0.875 mg/kg Hg2+-treated animals, and panels C, F, I are from 1.75 mg/kg Hg2+-treated animals. Panels A-C 
show phase-contrast images of the same fields in D-F and G-I, respectively. D-F show total nuclei labeled in each field by DAPI 
fluorescence, G-I show nuclei labeled by ethidium homodimer. The scale bar in the top left image represents 100 μm.BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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necrosis in the proximal tubule and, possibly, other seg-
ments of the nephron.
Conclusion
In this study, we describe a novel renal assay to detect
necrosis that involves the infusion of ethidium
homodimer into the intact rat kidney. Results of this study
indicate that this simple and sensitive perfusion tech-
nique can be used to evaluate necrosis in the proximal
tubule with the three-dimensional cyto-architecture
intact.
Methods
Materials
HgCl2  (#M1136), creatinine (#C4255), sterile 0.9%
sodium chloride (#8776), CdCl2 (#C3141), gentamicin
(#G3632) and other chemicals were of high purity and
were purchased from Sigma Chemical Company (St.
Louis, MO). Ethidium homodimer-1 (#E1169) and 4',6-
diamidino-2-phenylindole (DAPI) (#D1306) was pur-
chased from Invitrogen, Eugene, OR. Coomassie® Plus
Protein Assay Kit (#23236) and bovine serum albumin
(#23209) were purchased from Pierce, (Rockford, IL). Sat-
urated picric acid solution (#80456) was purchased from
Fluka Biochemika (Buchs, Switzerland).
Animals, Hg2+, Cd2+ and gentamicin treatment protocols
Adult male Sprague-Dawley rats were purchased from
Harlan, (Indianapolis, IN) and were randomly assigned to
the Hg2+-treated or control (sterile 0.9% NaCl) groups (n
≥ 6 for all treatment groups). Rats were given a single
intraperitoneal (ip) injection of Hg2+ at doses of (0.4375,
0.875, 1.75, 3.5 mg/kg) in sterile 0.9% NaCl solution. The
varying Hg2+ doses correlate to 1.6 μmol, 3.2 μmol, 6.5
μmol and 12.9 μmol Hg2+/kg body wt, respectively. Con-
trol animals received a single ip injection of the 0.9%
Dose-dependent increase in the percent ethidium-labeled proximal tubule epithelial cells in the renal cortex following treat- ment with Hg2+ Figure 6
Dose-dependent increase in the percent ethidium-labeled proximal tubule epithelial cells in the renal cortex following treat-
ment with Hg2+. Digital images from three fields per microscope slide with a total of four slides from each animal were quanti-
fied for necrosis analysis. Each animal represents one n value or replicate, in each treatment group. The values for each data 
point represent the mean ± SE for a total of n ≥ 6 for each treatment group. Asterisk (*) indicates significant differences from 
0.9% NaCl vehicle control treatment group (one-way ANOVA, p < 0.001, post-hoc Tukey's Test).BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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NaCl vehicle alone. The total volume of fluid injected for
Hg2+ and control animals was less than 1 ml. After ani-
mals were dosed with either Hg2+ or vehicle NaCl, they
were placed in individual metabolic cages, and 24 h urine
samples were collected. To further validate the utility of
this in situ viability assay, we examined changes in proxi-
mal tubule cell viability in male Sprague-Dawley rats after
6-week sub-chronic Cd2+ (n ≥ 6) exposure and acute gen-
tamicin dosing (n = 2). Briefly, animals were treated by
subcutaneous injection (sc) of CdCl2 at a Cd2+ dose of 0.6
mg/kg in sterile 0.9% NaCl, 5 days per week, for 6 weeks.
This dose correlates to 5 μmol Cd2+/kg body wt and has
been shown to cause proximal tubule dysfunction with-
out causing significant necrosis of the proximal tubule
epithelium [38]. Animals in the Cd2+-control group
received daily, equal volume, sc injections of 0.9% NaCl
alone. Gentamicin-treated animals were given daily injec-
tions of gentamicin at 100 mg/kg (71.9 μmol/kg) for eight
consecutive days. Gentamicin control animals were given
ip injection for 8 days with vehicle alone of physiological
saline solution, (PSS). This dosing protocol has been
shown to cause proximal tubule damage in rats [36].
Urinalysis
Following each of the treatment protocols the animals
were placed in individual metabolic cages and 24 h urine
samples were collected. The urine volumes were recorded
and the urine samples were aliquoted and stored at -80°C
until analyzed for protein and creatinine content. Urinary
creatinine was determined by a modified form of the
The effects of gentamicin and Cd2+ on cell membrane integrity Figure 7
The effects of gentamicin and Cd2+ on cell membrane integrity. Animals were treated with either Cd2+ (0.6 mg/kg, sc 5 days a 
week for 6 weeks) or gentamicin (100 mg/kg ip per day for 8 days) and the left kidneys were infused with ethidium homodimer. 
Cryosections of the kidneys were then fixed, permeabilized and labeled with DAPI as described in the Methods section. Panels 
A-D are phase contrast images corresponding to DAPI-labeled panels E-H and ethidium homodimer labeled nuclei in panels I-
L. Gentamicin treatment resulted in increased ethidium homodimer labeling (J) in the renal cortex as compared to control (I). 
No differences in ethidium homodimer labeling were detected in 6-week Cd2+-treated images (L) compared to control (K). 
The scale bar in the top left image represents 100 μm.BMC Physiology 2007, 7:1 http://www.biomedcentral.com/1472-6793/7/1
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colorimetric method of Shoucri and Pouliot [52]. Briefly,
3 ml of a working reagent that consisted of 0.21 M NaOH
and 2.4 mM picric acid was added to 20 μl urine samples.
After 10 min, the absorbance at a wavelength of 505 nm
was measured. Urine creatinine values were determined
based on the resulting absorbances of known creatinine
standards and were expressed as mg/kg/24 h. Urinary pro-
tein was determined by the method of Bradford [53] using
the Coomassie® Plus Protein Assay kit (Pierce #23236).
Determination of blood urea nitrogen (BUN) and plasma 
creatinine
Serum creatinine was assayed using the same method as
described above for urinary creatinine. BUN was assayed
following the protocol of Talke and Schubert [54].
In situ evaluation of cell viability
The animals were anesthetized [ketamine/xylaxine (67/7)
mg/kg]. The abdominal cavity was opened and the left
kidney was isolated from surrounding connective tissue.
The aorta was freed from the surrounding connective tis-
sue and from the adjacent vena cava. A 4.0 silk ligature
(Roboz Surgical, Gaithersburg, MD) was positioned
around the aorta as far caudally as possible (approxi-
mately 2 cm below left renal artery) and tied immediately.
A second ligature was position around the aorta just above
the left renal artery and tied just prior to the insertion of
the catheter. In order to allow for an isolated perfusion of
the left kidney, a third ligature was tied around the right
renal artery and vein to prevent perfusion of the right kid-
ney, just prior to insertion of the perfusion catheter. The
perfusion catheter was fashioned from a 23 gauge stain-
less steel needle and connected to polyethylene (PE 50)
tubing filled with a solution of 5 μM ethidium
homodimer in PSS which contained (mM): 115.0 NaCl,
5.5 glucose, 16.0 NaHCO3, 1.0 MgCl2, 0.2 Na2HPO4, 0.8
NaH2PO4, 1.0 CaCl2, and 5.0 KCl. An incision was made
approximately half way through the aorta just above the
lower ligature and the catheter was inserted into the aorta
and advanced to a position just below the left renal artery.
The catheter was tied and secured in place with a new lig-
ature. At this time a blood sample was taken from the infe-
rior vena cava. Once the catheter was secured, the ureter
was sectioned and ethidium homodimer was perfused
through the kidney at a flow rate of 1 ml/min for 5 min
then increased to 3 ml/min for 5 min. The pressure of the
perfusate was 50 mmHg at a flow rate of 1 ml/min and
100 mmHg at 3 ml/min, as measured in preliminary
experiments with a low pressure transducer (Grass P10EZ)
attached to a Model 7 Grass polygraph (Grass Technolo-
gies/Astro-Med, Inc., West Warwick, R.I.). The left kidney
was then perfused with PSS at 3 ml/min for 10 min to
wash out any residual or unbound ethidium homodimer.
The perfused left kidney was removed, decapsulized, cut
through the transverse plane into three sections and
immediately frozen separately at -80°C for later cryosec-
tioning. The non-perfused right kidney was also removed
and processed for histological and biochemical analyses.
Animals were then euthanized by exsanguination and
pneumothorax while under anesthesia.
The frozen left kidney samples were cryosectioned at a
thickness of 5 μm. The sections were then mounted on
glass slides, fixed and permeabilized in -20°C methanol,
and stained with 0.3 μM DAPI, to label all nuclei. The
labeled sections were then covered with Aqua Polymount
(Polysciences, Warrington, PA) and viewed with a Nikon
Eclipse 400 fluorescence microscope within 24 h of DAPI
staining. Fields were viewed under both phase contrast
and fluorescent illumination using a 40×, high power
objective or 10× low power objective. The number of total
nuclei and ethidium-labeled nuclei within the field of
view of a 40× objective, were determined from random
fields within the renal cortex. Each field contained
approximately 300 cells in an area of 9.1 × 104μm2. Dig-
ital images from three fields per slide with a total of four
slides from each animal were quantified for viability anal-
ysis. Digital images were captured with a Spot digital cam-
era (Diagnostic Instruments, Sterling Heights, MI) using
automated exposure times and gain settings for the bright-
field images. The dark-field fluorescence images of ethid-
ium homodimer (excitation = 528 nm; emission = 617
nm) and DAPI (excitation = 358 nm; emission = 461 nm)
stained slides were captured at a gain setting of 4 and 1 s
exposure for green, red and blue. The digital images were
processed using Image-Pro Plus imaging analysis software
package (Media Cybernetics, Silver Spring, MD). In per-
forming these studies, we found that once the tissue is fro-
zen in embedding medium and stored at -80°C, the
ethidium labeling is very stable with no loss of fluores-
cence over at least 2 months. However, once the tissue sec-
tions are cut with a cryotome, washed, stained with DAPI
then stored at room temperature there was a subsequent
loss of fluorescence over 1–4 weeks. Accordingly, all sam-
ples were examined within 48 hours following sections
and DAPI labeling.
Statistical Anaylsis
Data were analyzed using the SigmaStat® statistical pro-
gram (SPSS Inc., Chicago, IL). Statistical differences were
determined using one-way or two-way analysis of vari-
ance (ANOVA) where appropriate. If significant differ-
ences between sample means were detected (p < 0.05), a
post-hoc Tukey-Kramer test was performed to ascertain
which mean values were significantly different from con-
trol values.
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